Fig. 3

Univariable hazard Ratios (HR) and 95% Confidence Intervals (CI) of ASCVD risk enhancers for borderline/intermediate-risk groups according to the 2019 ACC/AHA guideline on the Primary Prevention of Cardiovascular Disease with Incident all-CVD during the median 10-year (a) and 15-year (b) follow-up: Tehran Lipid and Glucose Study 1999–2016. ASCVD atherosclerotic cardiovascular disease, WC waist circumference, FPG fasting plasma glucose, CKD chronic kidney disease, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, TG triglyceride, Mets metabolic syndrome, CVD cardiovascular disease, GDM gestational diabetes, HDP hypertensive disorders pregnancy. Elevated TG: TG ≥ 175 mg/dl; Elevated LDL-C: LDL-C ≥ 160 mg/dl. E: number of the event; N: number of sample size. *HDP and Premature menopause Reported only among females